However, this approach yielded different results in the CAPAN-2 model, where the most favorable response was observed with a single 4-Gy fraction coupled with 1 × 105 anti-mesothelin CAR-T cells, maintaining tumor volumes below 500 mm3 and ensuring mouse survival for up to 75 days post-implantation. Here, MSLN is linked to neoplasm.